Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-24

FDA Approved: NUVESSA — Original Application (Exeltis USA, Inc.)

View source ↗

Summary

FDA approved NUVESSA (metronidazole) under an Original Application from Exeltis USA, Inc., branding a new product for the treatment of bacterial vaginosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUVESSA (Metronidazole)

Snippet

ORIG AP for NUVESSA (METRONIDAZOLE)